ARTICLE | Company News
Cellestis, Qiagen deal
September 5, 2011 7:00 AM UTC
Qiagen completed its acquisition of diagnostics company Cellestis for A$3.80 per share. The price values Cellestis at about A$359 million ($382.3 million) (see BioCentury, July 18). ...